The Value of 18F-FDG PET/CT in evaluating disease severity in idiopathic pulmonary fibrosis

U. Ko (Seoul, Republic of Korea)

Source: International Congress 2017 – ILDs: clinical aspects
Session: ILDs: clinical aspects
Session type: Thematic Poster
Number: 850
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
U. Ko (Seoul, Republic of Korea). The Value of 18F-FDG PET/CT in evaluating disease severity in idiopathic pulmonary fibrosis. 850

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Value of 18F-FDG PET/CT for predicting postoperative acute exacerbation in idiopathic pulmonary fibrosis
Source: International Congress 2017 – ILDs: clinical aspects
Year: 2017


Prognostic value of dual-time-point 18F-FDG PET in fibrotic idiopathic interstitial pneumonia
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013

The utility of 18F-FDG PET/CT in chronic sarcoidosis
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013

Computed tomography lung parenchymal descriptions in routine radiological reporting have diagnostic and prognostic utility in patients with idiopathic pulmonary arterial hypertension and pulmonary hypertension associated with lung disease
Source: ERJ Open Res, 8 (1) 00549-2021; 10.1183/23120541.00549-2021
Year: 2022



Measurement of hypoxia in the lung in idiopathic pulmonary fibrosis: an F-MISO PET/CT study
Source: Eur Respir J, 58 (4) 2004584; 10.1183/13993003.04584-2020
Year: 2021



Clinical course and changes in high-resolution computed tomography findings in patients with idiopathic pulmonary fibrosis without honeycombing
Source: International Congress 2015 – New insights into IIPs
Year: 2015


CT and FDG PET/CT findings of pulmonary involvement in methotrexate-associated lymphoproliferative disease
Source: International Congress 2018 – CC6 Interstitial lung diseases
Year: 2018


Computed tomographic biomarkers in idiopathic pulmonary fibrosis
Source: International Congress 2019 – PG5 Novel insights into the diagnostic algorithm for interstitial lung diseases
Year: 2019


The 18F PET/CT scan in patients with chronic sarcoidosis
Source: International Congress 2016 – Sarcoidosis
Year: 2016


Novel evaluation of pulmonary hypertension with chronic lung disease by perfusion SPECT/CT
Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension
Year: 2019


Evaluation of pleural disease with FDG-PET imaging
Source: Annual Congress 2003 - Early lung cancer diagnosis
Year: 2003


Idiopathic pulmonary fibrosis: airway volume measurement identifies progressive disease on computed tomography scans
Source: ERJ Open Res, 6 (1) 00290-2019; 10.1183/23120541.00290-2019
Year: 2020



The role of lung ultrasonography in the assessment of idiopathic pulmonary fibrosis –correlation with HRCT finding
Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia
Year: 2019


Utility of FDG-PET in the diagnosis of pulmonary nodules
Source: Eur Respir J 2003; 22: Suppl. 45, 245s
Year: 2003

Volumetric CT analysis of normal lung as a predictor of mortality in idiopathic pulmonary fibrosis
Source: International Congress 2016 – IPF: from pathogenesis to treatment II
Year: 2016


Predictive value of 18F-FDG PET/CT for chemotherapy-related acute exacerbation of interstitial lung disease in lung cancer patients with interstitial lung disease
Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis
Year: 2019


Assessment of disease severity using imaging scores in pulmonary sarcoidosis
Source: Annual Congress 2012 - Diffuse parenchymal lung disease II
Year: 2012


Importance of computed tomography in defining segmental disease in chronic thromboembolic pulmonary hypertension
Source: ERJ Open Res, 6 (4) 00461-2020; 10.1183/23120541.00461-2020
Year: 2020



Longitudinal high-resolution computed tomography (HRCT) assessment and disease progression in patients with Idiopathic Pulmonary Fibrosis (IPF) on antifibrotic therapy
Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis
Year: 2019

High-resolution computed tomography pattern reflects pathophysiologic difference in acute exacerbation of idiopathic interstitial pneumonia
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013